1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Alliant Energy reported 2025 GAAP earnings of $3.14 per share, up from $2.69 in 2024, and ongoing earnings of $3.22 per share, up from $3.04. The company affirmed its 2026 ongoing EPS guidance of $3.36 to $3.46. Fourth-quarter results were weaker, with GAAP EPS of $0.55 versus $0.58 and ongoing EPS of $0.60 versus $0.70 a year earlier.
Full-year 2025 GAAP EPS of $3.14 vs. $2.69 in 2024; ongoing EPS of $3.22 vs. $3.04, which the company says is 6% growth.
Fourth-quarter 2025 GAAP EPS of $0.55 vs. $0.58 in Q4 2024; ongoing EPS of $0.60 vs. $0.70.
2026 ongoing EPS guidance of $3.36 to $3.46 affirmed, not changed.
Fidelity National Financial reported fourth quarter 2025 results on February 19, 2026. The company posted a net loss attributable to common shareholders of $117 million, or $0.43 per diluted share, compared with net earnings of $450 million, or $1.65 per share, a year earlier. The loss reflects a $471 million noncash deferred tax charge tied to the December 31, 2025 distribution of F&G shares to FNF shareholders, while adjusted net earnings rose to $382 million, or $1.41 per share.
Q4 2025 net loss attributable to common shareholders was $117 million, or $0.43 per diluted share, including a $471 million noncash deferred income tax charge
Q4 2025 adjusted net earnings were $382 million, or $1.41 per share, versus $366 million, or $1.34 per share, in Q4 2024
Total revenue was $4,051 million for Q4 2025, compared with $3,621 million for Q4 2024
FNF returned about $170 million to shareholders in Q4 2025 through $140 million of dividends and $30 million of share repurchases
Century Aluminum reported fourth-quarter 2025 net sales of $633.7 million, up slightly from the prior quarter, but net income attributable to stockholders fell to $1.8 million, or $0.02 per diluted share, from $14.9 million in the third quarter. Full-year 2025 net income was $41.8 million, down $295.0 million from 2024, and the company guided first-quarter 2026 Adjusted EBITDA attributable to stockholders to $215 million to $235 million.
Q4 2025 net sales $633.7 million versus $632.2 million in Q3 2025; Q4 net income $1.8 million, or $0.02 per diluted share
Q4 Adjusted net income $128.2 million, or $1.25 per share; Adjusted EBITDA attributable to stockholders $170.6 million
FY 2025 net sales $2.5 billion; FY net income $41.8 million, or $0.42 per diluted share, versus $336.8 million in 2024
Q1 2026 outlook: Adjusted EBITDA attributable to stockholders of $215 million to $235 million, citing higher energy costs from Winter Storm Fern
Valaris reported fourth quarter 2025 total operating revenues of $537 million, down from $596 million in the third quarter, and adjusted EBITDA of $97 million, down from $163 million. Net income rose to $717 million, but it included a $680 million tax benefit, and the company gave FY 2026 guidance for revenue of $2,125 million to $2,205 million and adjusted EBITDA of $485 million to $565 million. Valaris also said it will not hold future earnings calls or update guidance because of the pending business combination with Transocean.
Total operating revenues were $537 million, versus $596 million in Q3 2025; diluted EPS was $10.26, versus $2.65.
Net income of $717 million included a $680 million tax benefit; adjusted EBITDA fell to $97 million from $163 million.
FY 2026 guidance: total operating revenues of $2,125 million to $2,205 million and adjusted EBITDA of $485 million to $565 million, excluding costs tied to the Transocean deal announced February 9, 2026.
Valaris will not hold future earnings calls or provide updates to forward-looking guidance.
Metallus reported fourth-quarter 2025 net sales of $267.3 million and a net loss of $14.3 million, or $0.34 per diluted share, compared with a net loss of $21.4 million a year earlier and net income of $8.1 million in the third quarter of 2025. For full-year 2025, net sales rose 7% to $1.2 billion, but the company posted a net loss of $1.2 million, compared with net income of $1.3 million in 2024, and it expects first-quarter 2026 adjusted EBITDA to be higher than the fourth quarter.
Q4 2025 net sales of $267.3 million fell 13% from $305.9 million in Q3 2025 and rose 11% from $240.5 million in Q4 2024.
Q4 2025 net loss was $14.3 million, or $0.34 per diluted share, versus a net loss of $21.4 million, or $0.50 per share, in Q4 2024; adjusted net loss was $7.7 million, or $0.18 per share.
Full-year 2025 net loss was $1.2 million, or $0.03 per diluted share, versus net income of $1.3 million in 2024.
The company expects first-quarter 2026 shipments to increase approximately 10% from the fourth quarter and first-quarter adjusted EBITDA to be higher than Q4 2025.
Live Nation reported full-year 2025 revenue of $25.2 billion, up 9%, and operating income of $1.3 billion, up 52%, with adjusted operating income (AOI) up 10% to $2.4 billion. Net income attributable to common stockholders fell to $496 million from $896 million in 2024, as income tax expense moved to $340 million from a benefit of $392 million the year before. Management said it expects another year of double-digit operating income and AOI growth in 2026.
Full-year 2025 revenue of $25.2 billion, up 9%; AOI of $2.4 billion, up 10%
Operating income of $1.3 billion, up 52% from 2024
Net income attributable to common stockholders of $496 million, versus $896 million in 2024
Management expects double-digit AOI growth for full-year 2026; 2026 capital expenditures expected at $1.1 to $1.2 billion
World Kinect reported a fourth-quarter 2025 GAAP net loss of $280 million, or $5.11 per diluted share, after $247 million of impairments and $77 million of restructuring and exit costs, with revenue down 7% from a year earlier. For the full year, GAAP net loss was $614 million, or $10.99 per share, and adjusted EPS fell 12% to $1.91, while the company guided to 2026 adjusted EPS of $2.20 to $2.40.
Q4 2025 revenue was $9.03 billion, down 7%, and adjusted diluted EPS was $0.30 versus $0.62 a year earlier.
Full-year 2025 revenue was $36.92 billion, down 12%, and adjusted diluted EPS was $1.91 versus $2.18.
Q4 included $247 million of non-cash impairments, of which $169 million was goodwill, mainly in the Land segment.
For full-year 2026, the company expects adjusted diluted EPS in the range of $2.20 to $2.40.
F&G Annuities & Life reported fourth quarter 2025 net earnings attributable to common shareholders of $124 million, or $0.92 per diluted share, down from $323 million, or $2.50, a year earlier, while total revenues rose to $1.77 billion from $1.56 billion. Assets under management before flow reinsurance reached a record $73.1 billion, up 12%, but the company said it expects to close the sale of its Bermuda subsidiary in the first quarter of 2026, and lower profit is the main concern for shareholders.
Q4 2025 adjusted net earnings were $123 million, or $0.91 per share, versus $143 million, or $1.12 per share, in Q4 2024
Full year 2025 net earnings were $248 million, or $1.88 per share, versus $622 million, or $4.88 per share, in 2024
Full year 2025 gross sales were $14.6 billion, below the $15.3 billion record set in 2024
F&G expects to close the sale of F&G Life Re Ltd to Ancient Financial Holdings LP on March 1, 2026
Park Hotels & Resorts reported a fourth-quarter 2025 net loss of $204 million, or $(1.04) per diluted share, compared with net income of $73 million a year earlier, after $248 million of impairment expense mainly tied to Non-Core hotels. Adjusted EBITDA rose 10.1% to $152 million, and full-year 2025 Adjusted EBITDA fell 6.6% to $609 million. The company also gave a 2026 outlook of $580 million to $610 million in Adjusted EBITDA and named CFO Sean M. Dell'Orto as Chief Operating Officer while keeping his CFO role.
Q4 2025 comparable RevPAR was $182.49, up 0.8% year over year; full-year comparable RevPAR was $185.00, down 2.0%
Full-year 2025 net loss was $(277) million, or $(1.43) per diluted share, including $318 million of impairment expense
2026 outlook: Adjusted EBITDA of $580 million to $610 million and diluted EPS of $0.31 to $0.46
Dell'Orto was appointed COO effective February 12, 2026, with base salary raised to $675,000; he remains EVP, CFO and Treasurer
Casella Waste Systems reported fourth-quarter 2025 revenue of $469.1 million, up 9.7%, but a net loss of $2.5 million, compared with net income of $4.9 million a year earlier. For fiscal 2025, net income fell 41.9% to $7.9 million while Adjusted EBITDA rose 17.3% to $422.8 million, and the company issued fiscal 2026 guidance for revenue, net income, Adjusted EBITDA and cash flow.
Q4 2025 revenue was $469.1 million, up $41.6 million, or 9.7%, from Q4 2024; operating income fell 35.9% to $11.9 million.
Fiscal 2025 net income was $7.9 million, or $0.12 per diluted share, down 41.9%; Adjusted EBITDA was $422.8 million, up 17.3%.
Fiscal 2026 guidance: revenue of $1.970 billion to $1.990 billion, net income of $16 million to $22 million, and Adjusted EBITDA of $455 million to $465 million.
Conference call to discuss results is set for Friday, February 20, 2026, at 10:00 a.m. Eastern Time.
Akamai reported fourth-quarter and full-year 2025 results on February 19, 2026. Revenue rose 7% in the quarter and non-GAAP net income per diluted share rose 11%, but GAAP net income per diluted share fell 36% after a $55 million restructuring charge tied mainly to severance and intangible asset impairments. The company guided 2026 revenue to $4.400 billion to $4.550 billion, compared with $4.208 billion in 2025.
Q4 2025 revenue was $1.095 billion, up 7% year-over-year; Security revenue was $592 million, up 11%.
Q4 GAAP net income per diluted share was $0.58, down 36%; non-GAAP net income per diluted share was $1.84, up 11%.
The company recorded a $55 million restructuring charge in Q4 2025, primarily severance and intangible asset impairments.
2026 guidance: revenue of $4.400 billion to $4.550 billion and non-GAAP net income per diluted share of $6.20 to $7.20, versus $7.12 in 2025.
Harmonic reported preliminary unaudited results for the fourth quarter and fiscal 2025. Broadband revenue fell sharply from a year earlier, but backlog and deferred revenue rose 73%, and the company guided 2026 Broadband GAAP net revenue to $440 million to $480 million, compared with $360.5 million in fiscal 2025. Results also include a $57.5 million goodwill impairment on the Video business, which is being sold to Leone Media Inc. for $145 million in cash.
Q4 2025 Broadband net revenue was $98.2 million, down from $171.0 million in Q4 2024; fiscal 2025 revenue was $360.5 million versus $488.2 million.
Total company GAAP loss per share was $(0.49) for Q4 and $(0.38) for fiscal 2025, including a $57.5 million goodwill impairment on the Video business.
Backlog and deferred revenue rose 73% to $573.8 million; Q1 2026 GAAP Broadband net revenue guidance is $100 million to $105 million.
The $145 million Video business sale is expected to close in the first half of 2026, subject to closing conditions.
PTC Therapeutics reported fourth-quarter 2025 total revenue of $164.7 million, down from $213.2 million a year earlier, and a net loss of $135.0 million, wider than the $65.9 million loss in the prior-year quarter. For the full year, total revenue rose to $1,730.7 million and net income was $682.6 million, but both figures were lifted by a $998.4 million Novartis votoplam collaboration and license revenue item. The company also issued 2026 total product revenue guidance of $700 million to $800 million.
Q4 2025 total revenue was $164.7 million versus $213.2 million in Q4 2024; Q4 net loss was $135.0 million versus $65.9 million.
Q4 results include a $98.6 million change in the Translarna France sales allowance estimate, a life-to-date adjustment.
Full-year 2025 net income was $682.6 million, or $7.78 per diluted share, versus a net loss of $363.3 million in 2024.
2026 guidance: total product revenue of $700 million to $800 million, with the majority expected from Sephience.
Floor & Decor reported fourth-quarter fiscal 2025 net sales of $1,129.7 million, up 2.0%, but comparable store sales fell 4.8% and diluted EPS dropped 18.2% to $0.36. For the full year, net sales rose 5.1% to $4,684.1 million and diluted EPS edged up 1.1% to $1.92. The company also guided fiscal 2026 diluted EPS to $1.98 to $2.18, including a 53rd week.
Q4 net income of $39.3 million fell 17.2% from $47.5 million; operating income of $51.9 million fell 12.3%
Q4 comparable store sales decreased 4.8%; the company opened eight new warehouse stores in the quarter
Full-year fiscal 2025 diluted EPS of $1.92 compared with $1.90 in fiscal 2024
Fiscal 2026 guidance: net sales of approximately $4,880 million to $5,030 million and comparable store sales of approximately (2.0)% to 1.0%
Dropbox reported fourth-quarter and fiscal 2025 results. Q4 revenue was $636.2 million, down 1.1% year-over-year, and the company said it exceeded the high end of its revenue and operating margin guidance for the quarter. GAAP diluted EPS rose to $0.43 from $0.34, while non-GAAP diluted EPS fell to $0.68 from $0.73.
Q4 2025 revenue was $636.2 million, down 1.1%; excluding FormSwift, revenue grew 0.4%.
GAAP operating margin was 25.5%, up from 13.7%; non-GAAP operating margin was 38.2%, up from 36.9%.
Non-GAAP net income was $173.9 million, down from $222.6 million, mainly due to a higher tax provision and interest expense on the term loan.
Fiscal 2025 revenue was $2.521 billion, down 1.1%; the company repurchased about 60.4 million shares for $1.7 billion during the year.
Onto Innovation reported fourth-quarter 2025 revenue of $266.9 million, up 1.1% year over year, and full-year revenue of $1.005 billion, up 1.8%. Profit fell sharply: fourth-quarter GAAP diluted EPS was $0.21 versus $0.98 a year earlier, and full-year GAAP diluted EPS was $2.78 versus $4.06. The company guided first-quarter 2026 revenue to $275 million to $285 million.
Q4 2025 revenue $266.9 million, up 1.1% from $263.9 million; GAAP operating margin 5.2% versus 16.1%
Q4 2025 GAAP diluted EPS $0.21 versus $0.98; non-GAAP diluted EPS $1.26 versus $1.51
Full-year 2025 revenue $1.005 billion; a volume purchase agreement estimated at over $240 million was closed with an HBM manufacturer
Q1 2026 guidance: revenue $275 million to $285 million; GAAP diluted EPS $0.74 to $0.84; non-GAAP diluted EPS $1.26 to $1.36
Sensata Technologies reported fourth-quarter revenue of $917.9 million, up 1.1% from a year earlier, and full-year 2025 revenue of $3,704.5 million, down 5.8%. Full-year GAAP earnings per share fell to $0.21 from $0.85 after a $225.7 million goodwill impairment charge, while adjusted EPS was $3.42, down 0.6%; the company also guided first-quarter 2026 adjusted EPS to $0.81 to $0.85 versus $0.78 a year earlier.
Q4 2025 revenue $917.9 million, up from $907.7 million; diluted EPS $0.43 versus $0.04, and adjusted EPS $0.88, up 18.9%
Full-year 2025 revenue $3,704.5 million, down 5.8%; GAAP EPS $0.21 versus $0.85, including a $225.7 million non-cash goodwill impairment tied to Dynapower
Q1 2026 guidance: revenue $917 million to $937 million and adjusted EPS $0.81 to $0.85, compared with $911 million and $0.78 in Q1 2025
Full-year 2025 free cash flow $490.2 million; quarterly dividend of $0.12 per share paid November 26, 2025
Tandem Diabetes reported fourth-quarter and full-year 2025 results on February 19, 2026, and gave 2026 guidance. Worldwide sales rose 3% in the quarter to $290.4 million and 8% for the year to $1.015 billion, but the full-year GAAP net loss grew to $204.7 million from $96.0 million, including a $75.2 million acquired in-process research and development charge. The company expects 2026 sales of $1.065 billion to $1.085 billion, which would be above 2025 sales.
Q4 2025 GAAP operating income was $8.3 million, compared with an operating loss of $0.6 million a year earlier; Q4 net loss was $0.6 million versus net income of $0.8 million.
Full-year 2025 GAAP net loss was $204.7 million, or $3.04 per share, compared with $96.0 million, or $1.47 per share, in 2024.
2026 guidance: sales of $1.065 billion to $1.085 billion, gross margin of 56% to 57%, and adjusted EBITDA margin of 5% to 6%.
The company is moving to a pay-as-you-go model in the U.S. pharmacy channel, which the filing says creates a $70 million to $80 million headwind in 2026.
Middlesex Water reported 2025 net income of $42.8 million, down $1.5 million from 2024, and diluted EPS of $2.36 versus $2.47, while operating revenues rose about $2.8 million to $194.7 million. The New Jersey Board of Public Utilities approved a base rate increase of $14.5 million, which the company says supports its infrastructure investment plans, but the profit decline means shareholders see weaker earnings on the year.
2025 diluted EPS was $2.36, versus $2.47 in 2024; net income was $42.8 million, down $1.5 million.
Q4 2025 diluted EPS was $0.46, versus $0.49 in Q4 2024; Q4 net income was $8.6 million, versus $8.8 million.
NJBPU approved a $14.5 million annual revenue increase, with new rates effective February 23, 2026.
The company plans about $126 million of infrastructure investment in 2026 and $506 million from 2026 through 2028.
WillScot reported fourth-quarter 2025 revenue of $566 million, down from $603 million a year earlier, and a net loss of $187 million, driven mainly by a $302 million non-cash restructuring charge tied to its Network Optimization Plan. The company also gave 2026 guidance of approximately $2.175 billion in revenue and $900 million in Adjusted EBITDA, compared with $2.28 billion and $971 million for full-year 2025.
Q4 2025 diluted EPS was $(1.03) versus $0.48 a year earlier; Adjusted Diluted EPS was $0.29 versus $0.49.
The $302 million restructuring charge reflects accelerated depreciation on rental equipment identified for abandonment; the Board approved the plan on December 18, 2025.
The plan is expected to reduce annual real estate cost increases by approximately $25 million to $30 million over the next four years.
Full-year 2025 net loss was $53 million, and the company paid down $146 million of debt.
Newmont reported fourth-quarter 2025 adjusted net income of $2.8 billion, or $2.52 per diluted share, up from $1.9 billion, or $1.71, in the prior quarter, while GAAP net income fell to $1,301 million after a $779 million impairment and higher taxes. For 2026, it expects attributable gold production of about 5.3 million ounces and gold by-product all-in sustaining costs of $1,680 per ounce, compared with 5.9 million ounces and $1,358 per ounce in 2025, so output is guided lower and unit costs higher.
Q4 2025 net income attributable to stockholders was $1,301 million ($1.19 per diluted share), down $531 million from Q3, including a $779 million impairment tied to the Yanacocha Sulfides project deferral.
Full-year 2025 adjusted net income was $7.6 billion ($6.89 per diluted share), and free cash flow was $7.3 billion.
2026 guidance: attributable gold production of about 5.3 million ounces and gold by-product AISC of $1,680 per ounce.
Board declared a $0.26 per share dividend for Q4 2025, payable March 26, 2026; 2026 sustaining capital is about $1.95 billion and development capital about $1.4 billion.
Texas Roadhouse reported fourth-quarter 2025 total revenue of $1.48 billion, up 3.1%, but diluted earnings per share fell 26.1% to $1.28 as restaurant margin dropped on commodity inflation and the lapping of an extra week in the prior year. For fiscal 2025, revenue rose 9.4% to $5.88 billion while diluted EPS fell 5.8% to $6.10. The board also increased the quarterly dividend to $0.75 per share, and management said comparable restaurant sales rose 8.2% in the first seven weeks of 2026.
Q4 2025 total revenue $1.48 billion, up 3.1%; diluted EPS $1.28 vs. $1.73 a year earlier, down 26.1%
Fiscal 2025 diluted EPS $6.10 vs. $6.47, down 5.8%; fiscal revenue $5.88 billion, up 9.4%
Q4 restaurant margin 13.9% of sales vs. 17.0%; commodity inflation of 9.5% cited
Quarterly dividend of $0.75 per share payable March 31, 2026, to holders of record March 17, 2026
LegalZoom reported full-year 2025 revenue of $756.0 million, up 11%, and 2026 revenue guidance of $805 million to $825 million, about 8% growth at the midpoint. Net income fell 49% to $15.4 million, and the Board approved a $100 million increase to the stock repurchase program. Shareholders get a mix of top-line growth and guidance alongside lower reported profit and a larger buyback authorization.
Full-year 2025 revenue was $756.0 million, up 11%; net income was $15.4 million, down from $30.0 million in 2024.
Q4 2025 revenue was $190.3 million, up 18%; Q4 net income was $6.1 million, compared with $12.9 million a year earlier.
2026 guidance: revenue of $805 million to $825 million and Adjusted EBITDA of $190 million to $200 million.
The Board approved a $100 million increase to the stock repurchase program, which has no fixed expiration date.
Sprouts Farmers Market reported fourth-quarter and full-year 2025 results, with net sales and diluted earnings per share both higher than in 2024. For 2026, the company projects full-year diluted EPS of $5.28 to $5.44, close to the $5.31 it earned in 2025, and comparable store sales of -1% to 1%, with the first quarter expected to be weaker.
Q4 2025 net sales were $2.1 billion, up 8%, and diluted EPS was $0.92 versus $0.79 a year earlier
Full-year 2025 net sales were $8.8 billion, up 14%, and diluted EPS was $5.31 versus $3.75 in 2024
2026 outlook: full-year diluted EPS of $5.28 to $5.44 and comparable store sales growth of -1% to 1%; first-quarter comparable store sales of -3% to -1% and EPS of $1.66 to $1.70
Fiscal 2026 includes a 53rd week, which the company estimates adds about $0.21 to diluted EPS
Pool Corporation reported flat full-year 2025 net sales of $5.3 billion, while diluted EPS fell 4% to $10.85 and operating income fell 6% to $580.2 million, partly due to higher operating expenses. The company also issued 2026 diluted EPS guidance of $10.85 to $11.15 excluding ASU 2016-09 tax benefits, which it says reflects expectations for modest sales growth and improved earnings.
2025 net sales were $5.3 billion, comparable to 2024, with discretionary sales improving in the second half of the year
2025 diluted EPS was $10.85, down from $11.30 in 2024; excluding ASU 2016-09 tax benefits, EPS was $10.73 versus $11.07
Fourth-quarter 2025 net sales were $982.2 million, down 1%, and diluted EPS was $0.85 versus $0.98
2026 diluted EPS guidance is $10.85 to $11.15 without ASU 2016-09 tax benefits
Medical Properties Trust reported fourth-quarter 2025 net income of $17 million ($0.03 per share), compared with a net loss of $413 million a year earlier. For full-year 2025 it reported a net loss of $277 million ($0.46 per share), an improvement from a $2.4 billion loss in 2024, but normalized funds from operations (NFFO) fell to $346 million ($0.58 per share) from $483 million ($0.80 per share). The results include a one-time $18 million rent payment from Vibra Healthcare, which was recorded on a cash basis.
Q4 2025 net income was $17 million ($0.03 per share) versus a net loss of $413 million ($0.69 per share) in Q4 2024; Q4 NFFO was $107 million ($0.18 per share), essentially flat with $108 million a year earlier
Full-year 2025 NFFO was $346 million ($0.58 per share) versus $483 million ($0.80 per share) in 2024; full-year net loss narrowed to $277 million from $2.4 billion
A new lease for six California hospitals formerly operated by Prospect Medical Holdings is scheduled to ramp up to $45 million of annual rent in December 2026
The company repurchased about 4.5 million shares for $23.4 million and declared a regular quarterly dividend of $0.09 per share in February 2026
Integer Holdings reported fourth-quarter 2025 sales up 5% to $472 million and full-year sales up 8% to $1.854 billion, with full-year adjusted EPS up 21% to $6.40. GAAP diluted EPS from continuing operations fell 15% to $2.89 for the year, and the company narrowed its 2026 outlook around the midpoint of its October preliminary range. The company also plans an accelerated share repurchase of about $50 million, while total debt rose to $1.185 billion at December 31, 2025.
Q4 2025 sales rose 5% to $472 million; GAAP diluted EPS from continuing operations rose to $1.38 from $0.91.
Full-year 2025 GAAP diluted EPS from continuing operations fell 15% to $2.89; adjusted EPS rose 21% to $6.40.
2026 outlook: sales of $1.826 billion to $1.876 billion and adjusted EPS of $6.29 to $6.78.
Plans an accelerated share repurchase of about $50 million; total debt was $1.185 billion at December 31, 2025.
Southern Company reported fourth-quarter 2025 GAAP earnings of $416 million, or $0.38 per share, down from $534 million, or $0.49 per share, a year earlier. Excluding items such as debt extinguishment costs and an estimated Nicor Gas loss, earnings rose to $612 million, or $0.55 per share, and fourth-quarter operating revenues rose 10.1% to $7.0 billion, so shareholders see higher revenue and adjusted earnings but lower reported profit.
Q4 2025 GAAP earnings were $416 million ($0.38 per share) vs. $534 million ($0.49 per share) in Q4 2024.
Q4 2025 earnings excluding items were $612 million ($0.55 per share) vs. $544 million ($0.50 per share).
Full-year 2025 GAAP earnings were $4.3 billion ($3.94 per share) vs. $4.4 billion ($4.02 per share) in 2024.
Q4 2025 operating revenues were $7.0 billion, up 10.1% from $6.3 billion; full-year revenues were $29.6 billion, up 10.6%.
Radian reported fourth-quarter 2025 net income from continuing operations of $159 million, or $1.15 per diluted share, down from $164 million a year earlier, while revenue rose to $301 million. For the full year, net income from continuing operations fell to $618 million from $660 million, though diluted EPS rose to $4.39 from $4.28. Radian also completed its $1.67 billion acquisition of Inigo on February 2, 2026.
Q4 2025 net income from continuing operations was $159 million, or $1.15 per diluted share, versus $164 million, or $1.08, in Q4 2024.
Full-year 2025 net income from continuing operations was $618 million, or $4.39 per diluted share, versus $660 million, or $4.28, in 2024.
Q4 2025 total revenues were $301 million versus $293 million a year earlier; adjusted pretax operating income was $204 million versus $220 million.
Radian completed its acquisition of Inigo Limited on February 2, 2026, for $1.67 billion in a primarily all-cash transaction.
Upbound Group reported fourth-quarter 2025 revenue of $1,196.4 million, up 10.9% year over year, driven by the Brigit acquisition and Acima growth. Profit declined: GAAP diluted EPS was $0.34 versus $0.55, and non-GAAP diluted EPS was $1.01 versus $1.05. The company also issued full-year 2026 guidance of $4.70 billion to $4.95 billion in revenue and $4.00 to $4.35 in non-GAAP diluted EPS.
Q4 2025 consolidated revenue was $1,196.4 million, up 10.9% year over year; net earnings were $19.7 million, down from $31.0 million.
Full-year 2025 revenue was $4.7 billion, up 8.7%, and non-GAAP diluted EPS was $4.13, compared with $3.83 in 2024.
2026 guidance: revenue of $4.70 billion to $4.95 billion, adjusted EBITDA of $500 million to $535 million, and non-GAAP diluted EPS of $4.00 to $4.35.
First-quarter 2026 guidance: revenue of $1.16 billion to $1.26 billion and non-GAAP diluted EPS of $1.05 to $1.15.
Choice Hotels reported full-year 2025 net income of $370 million, up from $300 million in 2024, and record adjusted EBITDA of $626 million. Fourth-quarter net income fell to $64 million from $76 million, and full-year net income includes a $100 million one-time remeasurement gain. The company guided to 2026 net income of $265 million to $275 million, below the 2025 reported figure, and adjusted EBITDA of $632 million to $647 million.
Full-year 2025 diluted EPS was $7.90 versus $6.20 in 2024; Q4 diluted EPS was $1.37 versus $1.59.
Full-year 2025 adjusted EBITDA was a record $626 million, up from $604 million in 2024.
Global RevPAR fell 1.2% for full-year 2025; U.S. RevPAR fell 3.0%, while international RevPAR rose 3.5%.
2026 outlook: net income $265 million to $275 million, adjusted EBITDA $632 million to $647 million, adjusted diluted EPS $6.92 to $7.14.
LKQ reported fourth quarter 2025 revenue of $3.3 billion, up 2.7%, but Q4 diluted EPS fell 50.0% to $0.29 and adjusted diluted EPS fell 24.4% to $0.59. For full year 2025, revenue declined 1.3% to $13.7 billion and diluted EPS fell 8.7% to $2.31, and the company gave 2026 guidance of $2.90 to $3.20 adjusted diluted EPS. The Board also started a strategic review of alternatives on January 26, 2026, with no deadline and no assurance of any transaction.
Q4 2025 diluted EPS $0.29 vs. $0.58 a year earlier; adjusted diluted EPS $0.59 vs. $0.78, which included a $35 million pre-tax legal settlement benefit in Q4 2024
Full year 2025 revenue $13.7 billion, down 1.3%; diluted EPS $2.31 vs. $2.53
2026 outlook: adjusted diluted EPS $2.90 to $3.20; free cash flow $700 million to $850 million; organic parts and services revenue growth of (0.5%) to 1.5%
Restructuring plan expected to bring $60 million to $70 million in charges and more than $50 million in annualized savings
Laureate reported fourth-quarter 2025 revenue of $541.4 million, up 28%, and operating income of $179.5 million, up from $124.2 million. For full-year 2025, revenue rose 9% to $1,701.9 million, but net income fell to $283.8 million from $296.4 million, mainly due to foreign exchange effects. The board also raised its share repurchase authorization by $150 million to $400 million and gave 2026 revenue and Adjusted EBITDA guidance above 2025 levels.
Q4 2025 operating income was $179.5 million versus $124.2 million; diluted EPS was $1.17 versus $0.62, including a $56.9 million discrete tax benefit.
Full-year 2025 diluted EPS was $1.89 versus $1.92; Adjusted EBITDA rose to $518.9 million from $450.1 million.
2026 outlook: revenue of $1,890 million to $1,905 million and Adjusted EBITDA of $583 million to $593 million; Adjusted EPS of $1.95 to $2.03.
Board raised the buyback program from $250 million to $400 million; about $181 million remains available after $219 million of cumulative repurchases.
Visteon reported fourth-quarter 2025 net sales of $948 million, up from $939 million a year earlier, but net income attributable to the company fell to $74 million from $125 million. For full-year 2025, net sales were $3,768 million, down from $3,866 million, and net income was $201 million, down from $296 million, while adjusted EBITDA reached a record $492 million. The company also guided 2026 sales to $3.625 billion to $3.825 billion and raised its quarterly dividend 36% to $0.375 per share.
Q4 diluted EPS was $2.67 versus $4.48 a year earlier; adjusted EPS was $2.96 versus $4.55. The company cited year-over-year changes in its valuation allowance assessment and a non-cash pension transfer charge.
Full-year 2025 diluted EPS was $7.28 versus $10.61 in 2024; record adjusted EBITDA was $492 million versus $474 million.
2026 guidance: sales of $3.625 billion to $3.825 billion, adjusted EBITDA of $455 million to $495 million, and adjusted free cash flow of $170 million to $210 million.
Board increased the quarterly dividend to $0.375 per share, payable March 16, 2026, to shareholders of record as of March 2, 2026.
N-able reported fourth-quarter 2025 revenue of $130.3 million, up 11.8% year over year, and a GAAP net loss of $7.2 million, compared with net income of $3.3 million a year earlier. The company said full-year 2025 results were all above its guidance and issued 2026 outlook calling for total revenue of $554 million to $559 million and adjusted EBITDA of $167 million to $171 million.
Q4 2025 total revenue $130.3 million, up 11.8% year over year (9.0% in constant currency); Q4 GAAP net loss $7.2 million, or $0.04 per diluted share
Q4 2025 non-GAAP net income $10.8 million, or $0.06 per diluted share; adjusted EBITDA $38.6 million, a 29.6% margin
Full-year 2025 revenue $511.4 million, up from $466.1 million; full-year 2025 GAAP net loss $17.0 million versus net income of $31.0 million in 2024
2026 outlook: total ARR $581 million to $586 million, revenue $554 million to $559 million, adjusted EBITDA $167 million to $171 million; Q1 2026 revenue $131 million to $132 million
Etsy reported fourth quarter 2025 revenue of $881.6 million, up 3.5% from a year earlier as reported, while net income fell 14.8% to $110.7 million and diluted earnings per share fell to $0.92 from $1.03. The company also agreed to sell its Depop unit to eBay for $1.2 billion in cash, with closing expected in the second quarter of 2026, and guided to slight gross merchandise sales growth for 2026 on continuing operations.
Q4 2025 gross merchandise sales (GMS) were $3.59 billion, down 3.8% as reported and up 2.4% excluding Reverb, which Etsy sold on June 2, 2025.
Full-year 2025 net income was $163.0 million, down 46.3%, and diluted EPS was $1.39 versus $2.35 in 2024.
Etsy agreed to sell Depop to eBay Inc. for $1.2 billion in cash; closing is expected in the second quarter of 2026.
First quarter 2026 GMS guidance is $2.38 billion to $2.43 billion, with the company expecting slight GMS growth for full-year 2026.
Cushman & Wakefield reported fourth-quarter 2025 revenue of $2.9 billion, its highest fourth quarter in company history, but swung to a net loss of $22.4 million after a $177.0 million impairment on its Greystone joint venture. For the full year, revenue rose 9% to $10.3 billion and adjusted diluted earnings per share rose 34% to $1.22, while GAAP net income fell $43.1 million to $88.2 million.
Q4 2025 net loss of $22.4 million, or $0.10 per diluted share, versus net income of $112.9 million, or $0.48 per diluted share, in Q4 2024
Q4 2025 included a one-time $177.0 million other-than-temporary impairment on the Greystone JV equity method investment
Q4 2025 adjusted diluted EPS of $0.54, up $0.06 or 13%; full-year 2025 adjusted diluted EPS of $1.22, up 34%
Full-year 2025 free cash flow of $293.0 million, up $126.0 million; $300.0 million of term loan principal prepaid and liquidity of $1.8 billion at December 31, 2025
Evergy reported fourth quarter 2025 GAAP EPS of $0.36, up from $0.34, and adjusted EPS of $0.42, up from $0.35. For full year 2025, GAAP EPS fell to $3.66 from $3.79, while adjusted EPS rose to $3.83 from $3.81. The company also initiated 2026 adjusted EPS guidance of $4.14 to $4.34 and a long-term adjusted EPS growth target of 6% to 8%+ through 2030, which matters to shareholders as the outlook for future earnings.
Q4 2025 GAAP net income was $84.3 million, or $0.36 per share, versus $78.2 million, or $0.34 per share, in Q4 2024
Full year 2025 GAAP EPS was $3.66 versus $3.79 in 2024; adjusted EPS was $3.83 versus $3.81
2026 adjusted EPS guidance range is $4.14 to $4.34, with a midpoint of $4.24; growth is expected to exceed 8% beginning in 2028
Quarterly dividend declared at $0.6950 per share, payable March 20, 2026 to holders of record as of March 10, 2026
Walmart reported fourth-quarter revenue of $190.7 billion, up 5.6%, and operating income of $8.7 billion, up 10.8%, for the quarter ended January 31, 2026. GAAP earnings per share fell to $0.53 from $0.65 because of a $2.1 billion loss in other gains and losses, while the company announced a new $30 billion share repurchase authorization and guided fiscal 2027 adjusted EPS to $2.75 to $2.85.
Q4 revenue of $190.7 billion, up 5.6%; operating income of $8.7 billion, up 10.8%.
Q4 GAAP diluted EPS of $0.53 versus $0.65 a year earlier; adjusted EPS of $0.74 excludes a $0.21 net loss on equity and other investments.
New $30 billion share repurchase authorization announced in February 2026, replacing the remaining capacity under the November 2022 authorization.
FY27 guidance: adjusted EPS of $2.75 to $2.85 versus FY26 adjusted EPS of $2.64; net sales (cc) expected to grow 3.5% to 4.5%.
UL Solutions reported fourth-quarter and full-year 2025 results on February 19, 2026. Revenue grew in both periods, but GAAP net income and diluted EPS fell in the fourth quarter because of a $37 million pre-tax restructuring charge. The company also gave a 2026 outlook calling for mid-single digit constant currency organic revenue growth and an Adjusted EBITDA margin of 26.5% to 27.0%, and raised its quarterly dividend 11.5% to $0.145 per share.
Q4 2025 revenue was $789 million, up 6.8%, with 5.7% organic growth; net income was $71 million, down 16.5%, and diluted EPS was $0.32 versus $0.40
Adjusted Diluted EPS was $0.53, up 8.2%; Adjusted EBITDA was $217 million, up 28.4%
Full-year 2025 revenue was $3,053 million, up 6.4%; diluted EPS was $1.60, down 1.2%
Quarterly dividend increases to $0.145 per share, payable March 12, 2026; the company also agreed on February 12, 2026 to sell its Employee Health and Safety software business, expected to close in Q2 2026
Pediatrix Medical Group reported fourth-quarter 2025 net income of $33.7 million, or $0.40 per diluted share, up from $0.36 a year earlier, while net revenue fell to $493.8 million from $502.4 million and Adjusted EBITDA fell to $65.8 million from $68.7 million. For full-year 2025, net income was $165.4 million, or $1.94 per share, compared with a net loss in 2024, and the company preliminarily expects 2026 Adjusted EBITDA of $280 million to $300 million.
Q4 2025 net revenue of $493.8 million vs $502.4 million in Q4 2024; same-unit revenue grew 4.0 percent, offset by practice dispositions
Q4 2025 net income of $33.7 million, or $0.40 per diluted share, vs $30.5 million, or $0.36, in Q4 2024; Adjusted EPS was $0.50 vs $0.51
Full-year 2025 net income of $165.4 million ($1.94 per share) vs a net loss of $99.1 million ($1.19 per share) in 2024
Preliminary 2026 Adjusted EBITDA outlook of $280 million to $300 million
Hims & Hers agreed to acquire all issued capital of Australian digital health company Eucalyptus for up to about $1.15 billion, including upfront, deferred and earnout payments. The company may pay part of the deferred and earnout amounts in its Class A common stock, which would add shares outstanding, and closing is expected in the middle of 2026, subject to regulatory and other conditions.
Upfront payments of about $240 million are due at closing, with deferred payments of about $710 million and earnout payments of up to about $200 million.
Hims & Hers may settle up to about 60% of the deferred and earnout payments in Class A common stock at its discretion.
Closing is anticipated in the middle of fiscal year 2026 and is subject to regulatory approvals, key contract consents and other conditions.
The company said it expects to fund most of the transaction with existing cash and future U.S. operating cash flow.
Gentherm reported fourth-quarter and full-year 2025 results on February 19, 2026, with product revenue up 8.5% in the quarter but net income down sharply from the prior year. The company also issued 2026 guidance of $1.5 billion to $1.6 billion in product revenue and a preliminary 2027 revenue outlook of about $1.7 billion, while the planned combination with Modine Performance Technologies is still pending.
Q4 2025 product revenue was $382.8 million, up 8.5% from $352.9 million; net income was $3.0 million versus $15.3 million, and GAAP diluted EPS was $0.10 versus $0.49
Q4 adjusted diluted EPS was $0.49 versus $0.29 a year earlier; gross margin was 23.7% versus 24.4%
2026 guidance: product revenue $1.5 billion to $1.6 billion, adjusted EBITDA $175 million to $195 million, adjusted free cash flow $80 million to $100 million; 2027 preliminary product revenue about $1.7 billion
Full-year 2025 product revenue was $1,498.6 million, up 2.9%, while net income was $18.3 million versus $64.9 million in 2024
YETI reported fourth quarter and full year 2025 results on February 19, 2026, with sales up 7% in the quarter and 2% for the year. Adjusted earnings per share fell in both periods, with tariff costs cited as a $0.15 hit in the quarter and $0.35 for the year. The company expects 2026 adjusted sales to grow 6% to 8% and adjusted EPS of $2.77 to $2.83, which would be a 12% to 14% increase.
Q4 2025 net sales rose 7% to $583.7 million; international sales rose 25% to $135.9 million.
Q4 adjusted EPS fell 8% to $0.92 from $1.00, while GAAP EPS rose 17% to $0.74 from $0.63.
Full year 2025 adjusted EPS fell 9% to $2.48 from $2.73; full year sales rose 2% to $1,868.5 million.
For 2026, YETI expects adjusted sales growth of 6% to 8%, adjusted EPS of $2.77 to $2.83, and free cash flow of $200 million to $225 million.
Deere reported first-quarter fiscal 2026 net income of $656 million, or $2.42 per share, down from $869 million, or $3.19 per share, a year earlier, even though net sales and revenues rose 13% to $9,611 million. The company raised its fiscal 2026 net income forecast to a range of $4.5 billion to $5.0 billion, which matters to shareholders because profit fell sharply in the quarter while sales grew.
Net income was $656 million, down 25% from $869 million; diluted EPS was $2.42 versus $3.19.
Net sales and revenues rose 13% to $9,611 million, with Construction & Forestry sales up 34% and Small Agriculture & Turf sales up 24%.
Production & Precision Agriculture operating profit fell 59% to $139 million, with operating margin at 4.4% versus 11.0%, citing higher tariffs, unfavorable sales mix and higher warranty expenses.
Fiscal 2026 net income guidance is $4.5 billion to $5.0 billion; the company expects Production & Precision Ag net sales to be down 5 to 10%.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.